Venous Leg Ulcer Clinical Trial
Official title:
Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Inferior Vena Cava Obstruction With or Without Combined Iliofemoral Obstruction
This study is a prospective, multicenter, non-randomized, single-arm study to evaluate the performance, safety, and efficacy of the GORE® VIAFORT Vascular Stent for treatment of symptomatic inferior vena cava obstruction with or without combined iliofemoral obstruction in adult patients.
A maximum of 35 clinical investigative sites across the U.S., Europe, Australia, and New Zealand will participate in this study. One hundred and eleven subjects are intended to be implanted with the GORE® VIAFORT Vascular Stent in this study, with a limit of 22 treated subjects per site and a minimum of 45 patients treated within the United States. Subjects will be evaluated through hospital discharge and return for follow-up visits at 1, 6, 12, 24, 36, 48, and 60 months post-treatment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03903692 -
A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers
|
N/A | |
Completed |
NCT03257254 -
Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)
|
||
Recruiting |
NCT03666754 -
Early Glue Saphenous Vein Ablation With Compression Versus Compression Alone in the Healing of the Venous Ulcer
|
N/A | |
Withdrawn |
NCT02912858 -
Intermittent Pneumatic Compression of the Foot vs Geko Plus R-2 Neuromuscular Electrostimulation Device in Venous Leg Ulcer Patients
|
N/A | |
Completed |
NCT02482038 -
Geko Venous Leg Ulcer Study
|
N/A | |
Completed |
NCT02652572 -
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
|
Phase 1 | |
Unknown status |
NCT01658618 -
Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer
|
N/A | |
Completed |
NCT05646121 -
Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
|
||
Completed |
NCT03077165 -
Dose-response Relationship Study of S42909 on Leg Ulcer Healing
|
Phase 2 | |
Completed |
NCT04461132 -
The Effect of Manual Lymphatic Drainage
|
N/A | |
Completed |
NCT05974982 -
Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers
|
Phase 1 | |
Completed |
NCT04011371 -
Cyanoacrylate Closure for Treatment of Venous Leg Ulcers
|
N/A | |
Not yet recruiting |
NCT03543007 -
Evaluating the Safety and Efficacy of GrafixPLâ„¢PRIME for the Treatment of Chronic Venous Leg Ulcers
|
N/A | |
Completed |
NCT03286140 -
Early Venous Reflux Ablation Ulcer Trial
|
N/A | |
Recruiting |
NCT05588583 -
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
|
N/A | |
Not yet recruiting |
NCT04613687 -
Efficacy and Safety of a New Compression System URGO BD001 in the Treatment of VLU (FREEDOM)
|
N/A | |
Recruiting |
NCT05549609 -
A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05089890 -
Clinical Investigation of Sorbact® Dressings
|
N/A | |
Not yet recruiting |
NCT03670329 -
Management of Infection Risk in Non-comparative Trial (MINT)
|
N/A | |
Completed |
NCT02921750 -
Investigation to Evaluate the Efficacy and Safety of Exufiber Versus Aquacel Extra in Moderately or Strongly Exuding Venous and Mixed Ulcers of Predominantly Venous Origin
|
N/A |